Advanced Ovarian Cancer
Links shared publicly online about this topic
Treatment for Advanced Ovarian Cancer Effective
disabled-world.com — “New treatment regimen shown effective against advanced ovarian cancer” View full resource at disabled-world.com
Most Recently Shared on June 6, 2010 at 11:31 pm By:
Disabled World Health Advocate and Health News
Treatment for Advanced Ovarian Cancer Effective http://ff.im/-lA8Uw
Phase 2 study of aflibercept for the treatment of advanced ovarian cancer with ascites - MPR
empr.com — “Sanofi-aventis and Regeneron Pharmaceuticals announced data from a Phase 2 trial for their fusion protein product, aflibercept (VEGF Trap), in the treatment of advanced ovarian cancer patients with recurrent symptomatic malignant ascites (SMA).” View full resource at empr.com
Most Recently Shared on June 11, 2009 at 6:34 pm By:
MPR News: Phase 2 study of aflibercept for the treatment of advanced ovarian cancer with ascites: Sanof.. http://tinyurl.com/mobhuq
Bevacizumab extends progression-free survival in women with advanced ovarian cancer
news-medical.net — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment regimen saw no worsening of their disease for 14.1 months, compared to 10.3 months for women receiving standard therapy.” View full resource at news-medical.net
Most Recently Shared on June 7, 2010 at 12:55 pm By:
Ovarian Cancer News: Bevacizumab extends progression-free survival in women with advanced ovarian cancer: Newly ... http://buzzup.com/zltp
Neoadjuvant Chemotherapy for Advanced Ovarian Cancer - OrganizedWisdom Health
bit.ly — “: Dr. Maurie Markman reports on a study that indicates neoadjuvant chemotherapy followed by surgery is an acceptable alternative to primary surgery in patients with advanced ovarian cancer.” View full resource at bit.ly
Most Recently Shared on October 9, 2010 at 5:19 pm By:
Neoadjuvant Chemotherapy for Advanced Ovarian Cancer: : Dr. Maurie Markman reports on a study that indicates neoad... http://bit.ly/a4qOql
New treatment regimen shown effective against advanced ovarian cancer
physorg.com — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment ...” View full resource at physorg.com
Most Recently Shared on June 6, 2010 at 4:50 pm By:
PhysOrg Health News Health News
New treatment regimen shown effective against advanced ovarian cancer http://tw.physorg.com/195047400
New treatment regimen shown effective against advanced ovarian cancer
eurekalert.org — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment regimen saw no worsening of their disease for 14.1 months, compared to 10.3 months for women receiving standard therapy.” View full resource at eurekalert.org
Most Recently Shared on June 6, 2010 at 6:53 pm By:
New treatment regimen shown effective against advanced ovarian cancer: (Fox Chase Cancer Center) Newly reported re... http://bit.ly/a8Fohc
Nanoparticles show potential as part of new therapy for advanced ovarian cancer
news-medical.net — “Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research.” View full resource at news-medical.net
Most Recently Shared on July 30, 2009 at 8:01 pm By:
Ovarian Cancer News: Nanoparticles show potential as part of new therapy for advanced ovaria.. http://buzzup.com/9aom
Topotecan Tanks in Advanced Ovarian Cancer - QualityPoint Technologies
qualitypointtech.net — “The latest attempt to improve on platinum/taxane by adding topotecan was unsuccessful, as were 4 previous trials. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on October 13, 2010 at 8:37 pm By:
Topotecan Tanks in Advanced Ovarian Cancer: The latest attempt to improve on platinum/taxane by adding topotecan w... http://bit.ly/a2x1PW
Does Bevacizumab Improve Outcomes in Advanced Ovarian Cancer? Video
vodpod.com — “Maurie Markman, M.D. (M.D. Anderson Cancer Ctr.) discusses important gynecologic abstracts to be presented at the 2010 Annual ASCO Mtg. to be held June 4-8, 2010. 04 June 10. : Dr. Maurie Markman previews the findings of the latest Gynecologic Oncology Group study as well as a provocative but preliminary study on the value of screening for ovarian cancer.” View full resource at vodpod.com
Most Recently Shared on June 4, 2010 at 4:47 pm By:
Paul Cacciatore Patient Advocate
Maurie Markman, M.D. (M.D. Anderson Cancer Ctr.) discusses important gynecologic abstracts to be presented at the 2010… http://bit.ly/a2FqDg
Novartis Phase III Trial Examining EPO906 (patupilone) For Patients With Advanced Ovarian Cancer Failed To Meet Primary Endpoint
medicalnewstoday.com — “Novartis announced that patupilone (EPO906) did not show a significant overall survival advantage in a phase III trial of patients with advanced ovarian cancer, refractory or resistant to platinum” View full resource at medicalnewstoday.com
Most Recently Shared on June 1, 2010 at 3:11 pm By:
MNT Ovarian Cancer Health News
Novartis Phase III Trial Examining EPO906 (patupilone) For Patients With Advanced Ovarian Cancer Failed To Meet Primar... http://mnt.to/3DkL
Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence
medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that projected improvements in recurrence-free survival and an only modes” View full resource at medicalnewstoday.com
Most Recently Shared on December 9, 2010 at 6:05 pm By:
MNT Ovarian Cancer Health News
Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence http://mnt.to/3NP9
Avastin Phase III Study Shows Positive Results In Women With Advanced Ovarian Cancer
medicalnewstoday.com — “Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a phase III study showed the combination of Avastin (bevacizumab) and chemotherapy followed by maintenance use of Avastin increased the time women” View full resource at medicalnewstoday.com
Most Recently Shared on February 27, 2010 at 4:04 pm By:
MNT Ovarian Cancer Health News
Avastin Phase III Study Shows Positive Results In Women With Advanced Ovarian Cancer http://mnt.to/3yfN #ovariancancer
Genentech Announces Positive Results Of Avastin Phase III Study In Women With Advanced Ovarian Cancer
medicalnewstoday.com — “Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that a Phase III study showed the combination of Avastin® (bevacizumab) and chemotherapy follo” View full resource at medicalnewstoday.com
Most Recently Shared on February 26, 2010 at 9:37 am By:
Genentech Announces Positive Results Of Avastin Phase III Study In Women With Advanced Ovarian Cancer Genentech, Inc... http://bit.ly/9W9nfb
EGEN, Inc. Announces That Phase II Clinical Trial For Advanced Ovarian Cancer Is Open For Enrollment
medicalnewstoday.com — “EGEN, Inc. announced that the first Phase II clinical trial utilizing EGEN-001 for the treatment of recurrent ovarian cancer is now open for enrollment. The trial is sponsored by the Gynecologic” View full resource at medicalnewstoday.com
Most Recently Shared on December 15, 2010 at 6:05 pm By:
MNT Ovarian Cancer Health News
EGEN, Inc. Announces That Phase II Clinical Trial For Advanced Ovarian Cancer Is Open For Enrollment http://mnt.to/3P6r #ovariancancer
Dose-Dense Chemotherapy Improves Both Overall And Progression-Free Survival In Advanced Ovarian Cancer
medicalnewstoday.com — “Women given a more intensive 'dose-dense' regimen of chemotherapy survive longer and have a higher-rate of progression free survival, concludes an Article published Online First in an upcoming edi” View full resource at medicalnewstoday.com
Most Recently Shared on September 22, 2009 at 11:12 am By:
Dose-Dense Chemotherapy Improves Both Overall And Progression-Free Survival In Advanced Ovarian Cancer: Women gi.. http://bit.ly/RqyWW
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Disabled World
Disabled World is managed by Lynn and Ian Langtree, a couple dedicated to assisting seniors and people with disabilities.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
News-Medical.Net
Stay up to date with the latest Ovarian Cancer news and research via News-Medical.Net
Advertisement
